Magdalena Cichewicz, PhD

Articles by Magdalena Cichewicz, PhD

Magdalena Cichewicz, PhD, on Improving AAV Gene Therapy With Synthetic Promoters

July 18th 2023

The scientist II at Senti Biosciences discussed the potential of synthetic promoters to improve target specificity in AAV vector-based gene therapies in retinal diseases and beyond.

Magdalena Cichewicz, PhD

Articles by Magdalena Cichewicz, PhD

Magdalena Cichewicz, PhD, on Improving AAV Gene Therapy With Synthetic Promoters

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK